Related Experiment Video
Updated: Jun 24, 2026

Continuous Manual Exchange Transfusion for Patients with Sickle Cell Disease: An Efficient Method to Avoid Iron Overload
Published on: March 14, 2017
Advances in management of thalassemia
1Department of Hematology, Bombay Hospital Institute of Medical Sciences, Mumbai, India. mbagarwal@hotmail.com
Abstract:
Thalassemias represent the most common single-gene disorder causing a major public health problem in India. Thalassemia and hemoglobinopathies probably developed over 7000 years ago as a defense against malaria. In simple terms, thalassemia is caused by a mutation in either the â-globin chain or the á-globin chain which combine equally in red cells to form hemoglobin. These mutations lead to varying degree of anemia resulting into thalassemia minor, intermedia or major. Present write up relates to advances in the management of â-thalassemia major.
Related Concept Videos
Diabetes: Management and Pharmacotherapy
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Cystic Fibrosis: Management
Sinus disease and chronic sinusitis...
Rheumatic Heart Disease III: Medical Management
Mitral Stenosis III: Medical Management
Bone Marrow Sampling and Transplants
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy the...
Myocarditis IV: Nursing Management
